DOI QR코드

DOI QR Code

Prevalence of Types of Cancers in the Elderly Covered by Insurance of the Islamic Republic of Iran Broadcasting Company in 2015 - Comparison with Younger Groups

  • Roshani, Zahra (Iranian Research Center on Aging, Department of Aging, The University of Social Welfare and Rehabilitation Sciences) ;
  • Kamrani, Ahmad Ali Akbari (Iranian Research Center on Aging, Department of Aging, The University of Social Welfare and Rehabilitation Sciences) ;
  • Shati, Mohsen (Iranian Research Center on Aging, Department of Aging, The University of Social Welfare and Rehabilitation Sciences) ;
  • Sahaf, Robab (Iranian Research Center on Aging, Department of Aging, The University of Social Welfare and Rehabilitation Sciences)
  • 발행 : 2016.06.01

초록

Presently, the world population of the elderly is growing. By improving health hygiene and welfare indicators, mortality and birth rates decrease and life expectancy increases, making the present century the century of elderly. Aging is one of the main risk factors for development of cancer, which itself is the second cause of death in old people. This study was conducted to assess the prevalence of cancer in the elderly covered by the Islamic Republic of Iran Broadcasting (IRIB) insurance program and to obtain suitable programs for cancer screening and early detection, increase patient survival, improve elderly care and to reclaim the cost of treatment in comparison to the national and international statistics. This is a cross-sectional study conducted on all elderly patients diagnosed with malignancy based on their pathology reports. In this study, of the total 75,500 patients covered by IRIB insurance, 17.2% belonged to the elderly group, males accounting for 53.3%. The most common cancers in old men were prostatic cancer (61.3%), colon cancer (10.3%) cancer of the hematologic system, bladder cancer (9.6%), lung cancer (9.1%), thyroid cancer (3.9%) and brain tumors (1.3%). In the elderly women, the most common cancers were breast cancer (80.1%), colon cancer (5.1%), thyroid cancers (4.4%), bladder and hematologic system malignancies (3.6), lung cancer (2.9%) and brain tumors (0.7%). In addition, the prevalence of cancer was almost the same as national and international statistics. With the exception of non-melanoma skin cancer no difference was shown in prevalence of cancer between IRIB elderly patients and the other groups of cancer patients in Iran.

키워드

참고문헌

  1. Akbari ME, Rafiee M, Khoei MA, Eshrati B, Hatami H (2011). Incidence and survival of cancers in the elderly population in Iran: 2001-2005. Asian Pac J Cancer Prev, 12, 3035-9.
  2. Al-Hashimi M, Wang XJ (2013). Breast cancer in Iraq, incidence trends from 2000-2009. Asian Pac J Cancer Prev, 15, 281-6.
  3. Al-Rikabi A, Husain S (2012). Increasing prevalence of breast cancer among Saudi patients attending a tertiary referral hospital: a retrospective epidemiologic study. Croatian medical journal. Croat Med J, 53, 239. https://doi.org/10.3325/cmj.2012.53.239
  4. Berger NA, Savvides P, Koroukian SM, et al (2006). Cancer in the elderly. Trans Am Clin Climatol Assoc, 117, 147-55.
  5. Cancer IAfRo. World cancer report (2014). Geneva: WHO.
  6. Daloii MN, Bahrami T, Tabrizi M (2014). Epithelial to mesenchymal transition concept in Cancer: Review article. Bimonth J Hormozgan Univ, 18, 183-94.
  7. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403. https://doi.org/10.1016/j.ejca.2012.12.027
  8. Hajjar R, Atli T, Al-Mandhari Z, et al (2013). Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol, 24, 11-24.
  9. Jazayeri S, Sadat S, Ramezani R, Kaviani A (2015). Incidence of Primary cancer in IRAN. Cancer Epi, 39, 519-27. https://doi.org/10.1016/j.canep.2015.04.016
  10. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin. 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Johnson CM, Wei C, Ensor JE, et al (2013). Meta-analyses of colorectal cancer risk factors. Cancer Causes Control, 24, 1207-22. https://doi.org/10.1007/s10552-013-0201-5
  12. Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. Najm, 343, 78-85.
  13. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 20, 2006-14.
  14. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  15. Muss H (2009). Cancer in the elderly: a societal perspective from the United States. J Clin Oncol, 21, 92-8. https://doi.org/10.1016/j.clon.2008.11.008
  16. National cancer Registry Report, Deputy for Health Directory, CDC cancer office Tehran, IRAN 2009.
  17. Noori Daloii M. Molecular genetics in third millennium: Valume. Tehran . Summer 2009.
  18. Noori Daloii M. Principles of Emeris Medical Genetics, Trinpi P, Elards: Jamenegar & Salemi Publishing; 2009.
  19. Onsory K, Ranapoor S (2011). Breast cancer and the effect of environmental factors involved. Mol Mar Biol Biotechnol, 1, 59-70.
  20. Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  21. Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G(2012). Prostate cancer in the elderly. Cancer, 118, 3062-70. https://doi.org/10.1002/cncr.26392
  22. Somi M, Mousavi S, Rezaeifar P, Naghashi S (2012). Cancer incidence among the elderly population in the Northwest of Iran: A population based study. Iran J Cancer Prev. 2, 117-26.
  23. Sweeney C, Blair CK, Anderson KE, Lazovich D, Folsom AR (2004). Risk factors for breast cancer in elderly women. Am J Epidemiol. 160, 868-75. https://doi.org/10.1093/aje/kwh276
  24. Syrgos KN, Karapanagiotou E, Harrington KJ (2005). Prostate cancer in the elderly. Anticancer Res, 25, 4527-33.
  25. Thakkar JP, McCarthy BJ, Villano JL (2014). Age-specific cancer incidence rates increase through the oldest age groups. Am J Med Sci, 348, 65-70. https://doi.org/10.1097/MAJ.0000000000000281
  26. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS (2012). Comparison of Cancer Incidence between China and the USA. Cancer Biol Med, 9, 128-32.
  27. www.who.int/cancers/screening-and-treatment.2014 Yang L, Fujimoto J, Qiu D, Sakamoto N (2010). Trends in cancer mortality in the elderly in Japan, 1970-2007. Ann Oncol, 21, 389-96. https://doi.org/10.1093/annonc/mdp303
  28. Yilmaz HH, Yazihan N, Tunca D, et al (2010). Cancer trends and incidence and mortality patterns in Turkey. Jpn J Clin Oncol. 51, 7-12